The Spinal Cord Injury Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Spinal Cord Injury Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Spinal Cord Injury treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Spinal Cord Injury (SCI) is a devastating event with sudden onset of motor and sensory dysfunction. Damage to autonomic neurons at and below the level of injury leads to bowel and bladder. Prevalence of this trauma was formerly found primarily in young patients due to high-energy accidents and contact sports. However, cervical canal stenosis is increasingly found in elderly patients with the progress of our aging society, and the susceptibility of elderly patients to easily injure their spinal cord from a fall.
There is no specific treatment for SCI patients, and currently, surgical intervention and subsequent rehabilitation are the only options for SCI treatment. Although methylprednisolone is administered at the acute stage of injury, a consensus of its use has not yet been reached from the aspects of both safety and effectiveness. Recent developments in stem cell research and numerous preclinical studies have demonstrated the effectiveness of neural precursor cell (NPC) transplantation in animal models of SCI.
Spinal Cord Injury Market Key Facts
-
The total prevalent population of Spinal cord injury (SCI) in the 7MM was 652,542 in 2017.
-
According to the analysts at Delveinsight, the highest prevalent cases of this disease were observed in the United States, which accounted for 294,000 cases in 2017.
-
The total prevalent cases for Spinal Cord Injury (SCI) were highest in the United States, followed by Germany and France. Spain accounted for the least number of prevalent cases among the 7MM.
-
In 2017, the incident population of SCI in Japan was found to be 5,058 cases, and the prevalence was estimated to be 100,000 cases.
-
According to the available literature, Vehicle crashes are the most recent leading cause of injury, closely followed by falls. Sports and work-related accidents are the other major causes of injury.
-
According to the latest updates from the NSCISC database, the incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the United States, or about 17,810 new SCI cases each year. Moreover, the estimated number of people with SCI living in the United States is approximately 294,000 persons, with a range from 250,000 to 368,000 persons.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/spinal-cord-injury-market
Key Benefits of Spinal Cord Injury Market Report
-
The market report provides an in-depth analysis of Spinal Cord Injury Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.
-
The report will help in developing business strategies by understanding the Spinal Cord Injury Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.
-
The market report covers the Spinal Cord Injury current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.
-
The report provides a detailed assessment of the Spinal Cord Injury market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors.
Spinal Cord Injury Market
The Spinal Cord Injury (SCI) market size shall grow during the forecast period, owing to the launch of upcoming therapies. Extensive research and development activities of pharmaceutical companies for developing the therapies for SCI will also significantly impact the market.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Spinal Cord Injury market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Spinal Cord Injury market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Spinal Cord Injury Epidemiology
The epidemiology section covers insights about the historical and current Spinal Cord Injury patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Spinal Cord Injury Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Spinal Cord Injury market or expected to get launched in the market during the study period. The analysis covers Spinal Cord Injury market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Spinal Cord Injury Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Companies across the globe are working toward the development of new treatment therapies for SCI, but few companies have made it to the clinical stage of development.
The dynamics of the Spinal Cord Injury market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of emerging therapies during the forecast period.
Request for Sample @ Spinal Cord Injury Therapeutics Market Assessment
Companies in the Spinal Cord Injury (SCI) Market includes:
-
AbbVie
-
StemCyte
-
Kringle Pharma
-
Lineage Cell Therapeutics
-
Nipro Corporation
-
ReNetX Bio, Inc.
And many others.
Spinal Cord Injury (SCI) Therapies covered in the report include:
-
MC001
-
AST-OPC1
-
KP-100IT
-
Elezanumab
-
Stemirac
-
AXER-204
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Spinal Cord Injury Competitive Intelligence Analysis
4. Spinal Cord Injury Market Overview at a Glance
5. Spinal Cord Injury Disease Background and Overview
6. Spinal Cord Injury Patient Journey
7. Spinal Cord Injury Epidemiology and Patient Population
8. Spinal Cord Injury Treatment Algorithm, Current Treatment, and Medical Practices
9. Spinal Cord Injury Unmet Needs
10. Key Endpoints of Spinal Cord Injury Treatment
11. Spinal Cord Injury Marketed Products
12. Spinal Cord Injury Emerging Therapies
13. Spinal Cord Injury Seven Major Market Analysis
14. Attribute Analysis
15. Spinal Cord Injury Market Outlook (7 major markets)
16. Spinal Cord Injury Access and Reimbursement Overview
17. KOL Views on the Spinal Cord Injury Market.
18. Spinal Cord Injury Market Drivers
19. Spinal Cord Injury Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/spinal-cord-injury-market
Latest Reports By DelveInsight
Spinal Cord Injury Pipeline Insights
Spinal Cord Injury Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across Spinal Cord Injury (SCI) Market.
Lennox Gastaut Syndrome Market
DelveInsight’ s “Lennox Gastaut Syndrome Market Insights, Epidemiology and Market Forecast – 2030” report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology and the Lennox Gastaut Syndrome market size, share, trends, and forecast for the seven major markets (i.e. the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/